Cargando…
Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway
The chiral molecule, apomorphine, is currently used for the treatment of Parkinson’s disease (PD). As a potent dopamine receptor agonist, this lipophilic compound is especially effective for treating motor fluctuations in advanced PD patients. In addition to its receptor-mediated actions, apomorphin...
Autores principales: | Heurtaux, Tony, Kirchmeyer, Melanie, Koncina, Eric, Felten, Paul, Richart, Lorraine, Uriarte Huarte, Oihane, Schohn, Herve, Mittelbronn, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560932/ https://www.ncbi.nlm.nih.gov/pubmed/34415465 http://dx.doi.org/10.1007/s10571-021-01131-1 |
Ejemplares similares
-
Microglia in Health and Disease: The Strength to Be Diverse and Reactive
por: Uriarte Huarte, Oihane, et al.
Publicado: (2021) -
Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant
por: Hoenen, Claire, et al.
Publicado: (2016) -
NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes
por: Gustin, Audrey, et al.
Publicado: (2015) -
Single-Cell Transcriptomics and In Situ Morphological Analyses Reveal Microglia Heterogeneity Across the Nigrostriatal Pathway
por: Uriarte Huarte, Oihane, et al.
Publicado: (2021) -
Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
por: Garcia, Pierre, et al.
Publicado: (2022)